Microbiology News and Research

RSS

Researchers discover mechanism behind loss of smell in people with COVID-19

Researchers have discovered a mechanism that may explain why people with COVID-19 lose their sense of smell.

2 Feb 2022

Study uncovers a class of microbial enzymes that drive ulcerative colitis

Ulcerative colitis, a subtype of inflammatory bowel disease, is a chronic ailment of the colon affecting nearly one million individuals in the United States. It is thought to be linked to disruptions in the gut microbiome - the bacteria and other microbes that live inside us - but no existing treatments actually target these microorganisms.

2 Feb 2022

Phico Therapeutics establishes Scientific Advisory Board

Phico Therapeutics Ltd today announced that it has established a Science Advisory Board (SAB) to provide strategic scientific guidance to the Company.

From Phico Therapeutics 1 Feb 2022

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according to a new discovery from Weill Cornell Medicine researchers.

31 Jan 2022

It’s Day 6 of covid, and a rapid antigen test comes back positive. stay home, say virologists.

What does it mean if a person's rapid antigen test result comes back positive after five days of isolation due to covid-19? According to the experts, that person is most likely still carrying a viral load high enough to infect others.

31 Jan 2022

Parasite present in seawater will help to explain how multicellularity developed in animals

Researchers from the UPV/EHU-University of the Basque Country and CEFAS have discovered a parasite present in seawater and which belongs to a primitive lineage; they have named it Txikispora philomaios.

29 Jan 2022

ERGA aims to provide genomic data to inform research about Europe's biodiversity

To provide important genomic data to inform research about Europe's biodiversity, scientists from 48 different countries initiated the "European Reference Genome Atlas" (ERGA) in 2021.

28 Jan 2022

Researchers receive $3.7 million to identify reasons for higher rates of cancers, other diseases in HIV patients

About 1.2 million people with HIV in the United States live relatively normal lives with uncompromised immune systems and the virus medically controlled.

27 Jan 2022

Unhealthy vaginal microbiome in mothers may contribute to infant deaths and altered development

A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in combination with an unhealthy diet contributed to increased pup deaths and altered development in the surviving babies.

27 Jan 2022

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Drug Administration, an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine.

26 Jan 2022

Serum biomarkers for SARS-CoV-2 reinfection identified in rhesus macaques

Many experts now predict that COVID-19, which so far has killed more than 5.5 million people worldwide, will remain endemic as new, infectious variants of SARS-CoV-2 emerge.

25 Jan 2022

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Transfusions of blood plasma donated by people who have recovered from COVID-19 may help patients hospitalized with the virus, a new international study shows.

25 Jan 2022

Study opens the door to a new approach to attacking herpesviruses

A new study published this week in mBio, an open access journal of the American Society for Microbiology, has opened the door to a new approach to attacking herpesviruses.

25 Jan 2022

Researchers discover a potential new way to combat antibiotic resistance

Researchers from Monash University have discovered a potential new way to prevent antibiotic resistance and reduce antibiotic intake.

25 Jan 2022

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

In a recent study posted to the Preprints with The Lancet* server, a large team of researchers estimated the comparative risk of hospitalization after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and Delta variants of concern (VOCs) in Denmark.

24 Jan 2022

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

A new approach that targets the cellular machinery that viruses need to reproduce – rather than the virus itself – appears to stem replication of a common childhood pathogen known as respiratory syncytial virus (RSV), UT Southwestern researchers report in a new study.

24 Jan 2022

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice.

21 Jan 2022

Mice study identifies ventral spinocerebellar tract neurons that control locomotion

For more than a century, scientists have known that while the commands that initiate movement come from the brain, the neurons that control locomotion once movement is underway reside within the spinal cord.

20 Jan 2022

New findings could contribute to future therapeutics for muscle degeneration

An international team led by uOttawa Faculty of Medicine researchers have published findings that could contribute to future therapeutics for muscle degeneration due to old age, and diseases such as cancer and muscular dystrophy.

19 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

Microbiology News and Research

Researchers discover mechanism behind loss of smell in people with COVID-19

Study uncovers a class of microbial enzymes that drive ulcerative colitis

Phico Therapeutics establishes Scientific Advisory Board

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

It’s Day 6 of covid, and a rapid antigen test comes back positive. stay home, say virologists.

Parasite present in seawater will help to explain how multicellularity developed in animals

ERGA aims to provide genomic data to inform research about Europe's biodiversity

Researchers receive $3.7 million to identify reasons for higher rates of cancers, other diseases in HIV patients

Unhealthy vaginal microbiome in mothers may contribute to infant deaths and altered development

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

Serum biomarkers for SARS-CoV-2 reinfection identified in rhesus macaques

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Study opens the door to a new approach to attacking herpesviruses

Researchers discover a potential new way to combat antibiotic resistance

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Mice study identifies ventral spinocerebellar tract neurons that control locomotion

New findings could contribute to future therapeutics for muscle degeneration

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Microplate-based assays in microbiology research eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®